JPRN-UMIN000001310招募中未知
An open-label prospective trial designed to evaluate the safety and efficacy of bronchoscopic lung volume reduction (BLVR) by autologous blood injection in emphysematous lung diseases - BLVR by Injecting Bioactive agent and Autologous blood (BIBA)
DMC COPD Research Group0 个研究点目标入组 10 人开始时间: 2008年8月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Evidence of active infection. 2) Evidence of systemic diseases or neoplasia expected to compromise survival during 5-yr period. 3) Any disease or condition that interferes with completion of initial or follow-up assessments. 4) Patients who are judged by the principal or other investigators to be not eligible for enrollment in the study.
研究者
相似试验
招募中
不适用
Clinical trial of PROTECT-C hand sanitizer in SARS-CoV-2 infected subjects.CTRI/2021/07/034624MIYAKAWA KOGYO INDIA PVT LTD
暂停
不适用
A clinical trial of NanoAgCide hand sanitizer on Coronavirus patients.CTRI/2020/10/028688WeInnovate Biosolutions Pvt Ltd
已完成
不适用
A clinical trial to find the efficacy and safety of Tubby nutririch lotion for the treatment of dry skin in infants and children.CTRI/2012/08/002876Sante Mernaud Pharmaceuticals Pvt Ltd15
招募中
4 期
Intravitreal Aflibercept for the treatment of previously treated exudative age-related macular degeneratioACTRN12612000666820Andrew Chang70
招募中
4 期
Intravitreal Aflibercept for the Treatment of Treatment Resistant Diabetic Macular OedemaDiabetic Macular OedemaEye - Diseases / disorders of the eyeACTRN12614001307695Andrew Chang50